3176 results for «382»
3176 results
CTO: imaging and devices
14 Apr 2021 – From EuroPCR 2021
Thanks to this session, learn how to recanalize a chronic total occlusion of the right coronary artery, how IVUS can facilitate and guide PCI to ostial left circumflex CTO, how hi-tech devices are also needed in calcified artery occlusions, and even more!
Coronary protection during TAVI - Many roads lead to Rome
28 Apr 2021 – From EuroPCR 2021
Thanks to this session, become familiar with techniques for left main coronary protection in ViV TAVI, get prepared for challenges of ostial coronary artery stenosis in a patient planned for TAVR, find out more about ViV TAVI with high risk of bilateral ostium occlusion, and more!
TAVI in a grey zone - Part 2
28 Apr 2021 – From EuroPCR 2021
Thanks to this session, study TAVI in case of Fabry disease, analyze severe aortic valve stenosis with cardiogenic shock requiring ECMO, get the chance to examine TAVI in challenging valve position with calcified aortic valve, and much more!
Percutaneous treatment of tricuspid regurgitation in 2021 - part 1
28 Apr 2021 – From EuroPCR 2021
This session will enable you to find out more about refractory heart failure in severe stand-alone tricuspid regurgitation, to study the one-shot transcatheter solution for torrential tricuspid regurgitation, and to witness full percutaneous three in one.
Coronary dissection - Part 1
28 Apr 2021 – From EuroPCR 2021
This session will help you know how to manage an iatrogenic intramural haematoma, how to treat a large pseudoaneurysm following PCI in SCAD, how to dissect flow-limiting spontaneous coronary, and much more!
Coronary dissection - Part 2
28 Apr 2021 – From EuroPCR 2021
Don't miss this session about iatrogenic dissection of aorta in a recanalization of a chronic total occlusion, LM dissection during PCI by decompression of false lumen, complication in a morbidly obese patient with STEMI, and more!
Opening Ceremony - Tokyo Valves 2020
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to see the slides of PCR Tokyo Valves 2020 opening ceremony, learn more about PCR's mission, charter, companions, and discover what makes this course unique.
Closing Ceremony - PCR Tokyo Valves 2020
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to see the slides of PCR Tokyo Valves 2020 closing ceremony, and discover who won the best clinical case and best abstract awards this year.
APSIC Fellowship ceremony
13 Dec 2020 – From AICT-AsiaPCR 2020
Discover the names of the new members of the APSIC Fellowship who showed excellence in the field of interventional cardiology and will continue to promote expertise, training, research, education, exchange, interaction across the Asia Pacific region.
This session was originally presented during AICT-AsiaPCR 2020.
Transcatheter electrosurgery and leaflet modification of the aortic valve
15 Feb 2026 – From PCR Tokyo Valves 2026
This session offers an expert overview of transcatheter electrosurgery and leaflet modification techniques for aortic valve interventions, focusing on TAV-in-SAV scenarios. It reviews patient selection, procedural setup, and material preparation, with detailed step-by-step guidance on BASILICA and UNICORN techniques, supported by recorded cases and troubleshooting strategies...
Complications and bailout strategies in transcatheter mitral interventions
15 Feb 2026 – From PCR Tokyo Valves 2026
This session addresses complications arising during transcatheter mitral edge-to-edge repair (TEER), focusing on identification, anticipation, and management strategies. It also highlights the importance of case selection to improve procedural safety, supported by detailed case analyses covering leaflet/device, access/septal, and hemodynamic complications.
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
POPular PAUSE TAVI - Continuation or interruption of oral anticoagulation during TAVI?
02 Sep 2024
Luis Ortega-Paz provides his take on the POPular PAUSE TAVI trial presented by Dirk Jan van Ginkel at the ESC Congress 2024 in London.
Author
Best of #AHA21 Scientific Sessions: coronary and valvular heart disease trials
14 Nov 2021
Vijay Kunadian provides summaries of study designs and findings in Interventional Cardiology released at the 2021 virtual edition of the American Heart Association Congress. View an infographic of the AVATAR late-breaking trial by Ali Nazmi Calik.
Author
ESC/EACTS Valvular Heart Disease Guidelines 2021: updates from the 2017 Guidelines
29 Aug 2021
There has been significant expansion in the field of structural heart diseases in the last couple of years, generating an extensive body of evidence and warranting an update to the 2017 Guidelines. Mirvat Alasnag provides an analysis of the updates included in this new document - a joint...
Author
Early intervention in patients with asymptomatic severe aortic stenosis and left ventricular myocardial fibrosis (EVOLVED)
30 Oct 2024
Ali Nazmi Calik provides his take on the EVOLVED trial presented by Marc Dweck at TCT 2024 in Washington.
Author
